Coming October 29: SITC releases its late-breaking abstract titles. We’ll add their presenting authors’ institutions to this guide once they’re out.

University of Alabama at Birmingham at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

University of Alabama at Birmingham brings 3 presentations to SITC 2026 in Phoenix. Its program spans new antibody-based drugs and how the site a tumor spreads to shapes the immune response. A distinctive study uses matched pancreatic cancer models to show that tumors in the liver build a different immune setting and leave CD8 T cells dysfunctional.

Organization	SITC 2026 Attendance
University of Alabama at Birmingham Birmingham, AL
	Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Clinical Activity and Immune Effector Toxicity Patterns of Tarlatamab in Relapsed/Refractory Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Exhibition Halls 4-6 · Poster 1007 Clinical · New agents Talk Fri Nov 6 5:15pm–5:30pm Part of Session 107a: Immuno-oncology at Immune-privileged Sites Matched pancreatic cancer model reveals site-specific immune architecture and CD8 + T-cell dysfunction associated with liver metastasis Hall A Tumor biology Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Dual-Antigen Targeting via a PMPC-Engineered Bispecific ADC Overcomes Tumor Heterogeneity and Enhances Anti-Tumor Efficacy in Advanced Ovarian Cancer Exhibition Halls 4-6 · Poster 914 New agents · Tumor biology

Organization

SITC 2026 Attendance

University of Alabama at Birmingham

Birmingham, AL

Poster

Fri Nov 6
12:15–1:45pm
5:30–7pm

Clinical Activity and Immune Effector Toxicity Patterns of Tarlatamab in Relapsed/Refractory Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Exhibition Halls 4-6 · Poster 1007

Clinical · New agents

Talk

Fri Nov 6
5:15pm–5:30pm

Part of Session 107a: Immuno-oncology at Immune-privileged Sites